Sample Stability Elecsys Troponin T hs Gen 6

• Conditions: acute myocardial infarction; heart attack; 10011082

• Registration Number: NL-OMON53855
• Lead Sponsor: Roche Diagnostics GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 July 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 75

Inclusion Criteria

Lower end of the Measuring range to 4.8 ng/L; >= 3 samples
>4.8 to 7.2 ng/L, >= 2 samples
19.2 to 18.8 ng/L, >= 2 samples
113.6 to 170.4 ng/L, >= 2 samples
>4.8 to 170.4 ng/L, >= 3 samples
>170.4 to 3000 ng/L, >= 1 sample
>3000 to 6000 ng/L, >= 1 sample
8550 to 9500 ng/L (upper 10% of the measuring range), >= 1 sample

Sample appearance: non-hemolytic, non-icteric, non-lipemic
Written Informed consent given.
Subject age >= 21 years

Exclusion Criteria

-Subject age < 21 years
-No written informed consent.
-Not able to provide 20 to 30 ml of blood (depending on the blood
collection tube type used), most preferred 2 or 3 times 20 to 30ml of
blood to collect more than one specimen type.
-Sample do not match requested analyte concentration.
-Sample do not match quality requirements (i.e. icteric, lipemic,
hemolytic)

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified